Möller A - Search Results

1

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, Andrews D, Mikeska T, Mangan NE, Samarajiwa SA, de Weerd NA, Gould J, Argani P, Möller A, Smyth MJ, Anderson RL, Hertzog PJ, Parker BS. Bidwell BN, et al. Among authors: moller a. Nat Med. 2012 Aug;18(8):1224-31. doi: 10.1038/nm.2830. Epub 2012 Jul 22. Nat Med. 2012. PMID: 22820642

2

Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.

Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL. Parker BS, et al. Among authors: moller a. J Pathol. 2008 Feb;214(3):337-46. doi: 10.1002/path.2265. J Pathol. 2008. PMID: 17985332

3

IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.

Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Möller A, Hill GR, Iwakura Y, Oft M, Smyth MJ. Teng MW, et al. Among authors: moller a. Proc Natl Acad Sci U S A. 2010 May 4;107(18):8328-33. doi: 10.1073/pnas.1003251107. Epub 2010 Apr 19. Proc Natl Acad Sci U S A. 2010. PMID: 20404142 Free PMC article.

4

Inflammation and immune surveillance in cancer.

Chow MT, Möller A, Smyth MJ. Chow MT, et al. Among authors: moller a. Semin Cancer Biol. 2012 Feb;22(1):23-32. doi: 10.1016/j.semcancer.2011.12.004. Epub 2011 Dec 24. Semin Cancer Biol. 2012. PMID: 22210181 Review.

5

Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy.

Wong CS, Sceneay J, House CM, Halse HM, Liu MC, George J, Hunnam TC, Parker BS, Haviv I, Ronai Z, Cullinane C, Bowtell DD, Möller A. Wong CS, et al. Among authors: moller a. Cancer Res. 2012 Apr 1;72(7):1694-704. doi: 10.1158/0008-5472.CAN-11-3310. Epub 2012 Feb 21. Cancer Res. 2012. PMID: 22354750

6

CD73-deficient mice are resistant to carcinogenesis.

Stagg J, Beavis PA, Divisekera U, Liu MC, Möller A, Darcy PK, Smyth MJ. Stagg J, et al. Among authors: moller a. Cancer Res. 2012 May 1;72(9):2190-6. doi: 10.1158/0008-5472.CAN-12-0420. Epub 2012 Mar 6. Cancer Res. 2012. PMID: 22396496

7

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

Sceneay J, Chow MT, Chen A, Halse HM, Wong CS, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ, Möller A. Sceneay J, et al. Among authors: moller a. Cancer Res. 2012 Aug 15;72(16):3906-11. doi: 10.1158/0008-5472.CAN-11-3873. Epub 2012 Jul 2. Cancer Res. 2012. PMID: 22751463

8

NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.

Chow MT, Sceneay J, Paget C, Wong CS, Duret H, Tschopp J, Möller A, Smyth MJ. Chow MT, et al. Among authors: moller a. Cancer Res. 2012 Nov 15;72(22):5721-32. doi: 10.1158/0008-5472.CAN-12-0509. Epub 2012 Sep 17. Cancer Res. 2012. PMID: 22986739

9

NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma.

Chow MT, Tschopp J, Möller A, Smyth MJ. Chow MT, et al. Among authors: moller a. Immunol Cell Biol. 2012 Nov;90(10):983-6. doi: 10.1038/icb.2012.46. Epub 2012 Sep 25. Immunol Cell Biol. 2012. PMID: 23010873

10

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone.

Slaney CY, Möller A, Hertzog PJ, Parker BS. Slaney CY, et al. Among authors: moller a. Oncoimmunology. 2013 Jan 1;2(1):e22339. doi: 10.4161/onci.22339. Oncoimmunology. 2013. PMID: 23482870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,220 results

Search Page